Pierce David A
Known title: DirectorCIK: 0001529751
Associated companies
this person other insiders at DHC
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Transaction History
| DHC | ▲ Buy | Grant | 20,000 | — | 6/5/2023 | View on chart |
| DHC | ▲ Buy | Grant | 20,000 | — | 6/2/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 1,726 | $76K | 3/1/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,444 | $0 | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 718 | $32K | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 1,761 | $76K | 2/23/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 1,884 | $80K | 2/22/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,493 | $0 | 2/21/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 732 | $31K | 2/21/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,668 | $0 | 2/18/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 784 | $33K | 2/18/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 2,354 | $101K | 2/18/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,333 | $0 | 2/17/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 979 | $42K | 2/17/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 1,956 | $86K | 2/16/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,769 | $0 | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 813 | $36K | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 6,161 | $268K | 1/4/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 8,982 | $0 | 1/1/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 2,821 | $120K | 1/1/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 42,934 | $317K | 12/20/2021 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,997 | $31K | 12/20/2021 | View on chart |
| BSX | ▼ Sell | Open Market | 49,988 | $2.0M | 12/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
DHC REITs Show Signs of Stabilization Amid Market Recovery
A recent report notes that Real Estate Investment Trusts have halted their recent decline, suggesting a potential shift in sentiment for the sector. DHC, as a healthcare-focused REIT, is part of this broader group. The stock currently trades near its support level, with a dividend yield of 1.94% and an average analyst target of $10.15.
DHC REITs Show Signs of Stabilization Amid Market Recovery. A recent report notes that Real Estate Investment Trusts have halted their recent decline, suggesting a potential shift in sentiment for the sector. DHC, as a healthcare-focused REIT, is part of this broader group. The stock currently trades near its support level, with a dividend yield of 1.94% and an average analyst target of $10.15.